Related Experiment Video
Updated: Jul 13, 2026

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models
Published on: March 13, 2018
Radiotracer breast cancer imaging: Beyond FDG and MIBI
Abstract:
Radiotracer imaging with MIBI and FDG have shown the benefit of the functional imaging of breast cancer. Newer radiopharmaceuticals targeted to particular aspects of breast cancer biology will likely play an important role in directing more specific and individualized breast cancer treatment. Future studies will need to test the ability of SPECT and PET imaging to detect breast cancer, but also to assess target expression, identify resistance factors, and measure early response to treatment. This will require protocols designed to test the predictive capability of imaging in the setting of a therapy trial, a new paradigm for breast cancer imaging, for which radiotracer imaging is ideally suited.
Insights
Functional imaging using radiotracers like MIBI and FDG aids breast cancer diagnosis. Future radiopharmaceuticals and imaging techniques (SPECT/PET) will enable personalized treatment by assessing tumor biology and response.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiopharmaceutical Science
Background:
- Radiotracer imaging, including MIBI and FDG, has demonstrated utility in functional breast cancer imaging.
- Emerging radiopharmaceuticals targeting specific breast cancer biology offer potential for personalized treatment strategies.
Purpose of the Study:
- To explore the future role of SPECT and PET imaging in breast cancer management.
- To evaluate the potential of advanced radiotracers for assessing tumor characteristics and treatment response.
Main Methods:
- Review of current and emerging radiotracer imaging techniques for breast cancer.
- Discussion of the integration of imaging into therapeutic trial protocols for predictive assessment.
Main Results:
- Functional imaging provides valuable insights into breast cancer biology.
- Newer radiopharmaceuticals are expected to enhance treatment specificity and individualization.
Conclusions:
- SPECT and PET imaging hold promise for detecting breast cancer, assessing target expression, identifying resistance, and measuring early treatment response.
- A new paradigm involving imaging in therapy trials is needed, for which radiotracer imaging is well-suited.
More Related Videos
09:5718F-Labeling of Radiotracers Functionalized with a Silicon Fluoride Acceptor (SiFA) for Positron Emission Tomography
Published on: January 11, 2020
12:24Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
Magnetic Resonance Imaging